Print

Targacept, Inc. (TRGT) to Present at the Stifel Nicolaus 2012 Healthcare Conference  
8/29/2012 9:54:19 AM

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that Alan A. Musso, Senior Vice President, Finance and Administration and Chief Financial Officer, is scheduled to present at the Stifel Nicolaus 2012 Healthcare Conference at Four Seasons Hotel Boston on Wednesday, September 5, 2012 at 1:30 p.m. Eastern Time.
//-->